WallStreetZenWallStreetZen

NASDAQ: BMEA
Biomea Fusion Inc Stock

$12.98-0.30 (-2.26%)
Updated Apr 12, 2024
BMEA Price
$12.98
Fair Value Price
$3.80
Market Cap
$465.84M
52 Week Low
$8.13
52 Week High
$43.69
P/E
-3.77x
P/B
2.75x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$117.26M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.18
Operating Cash Flow
-$97M
Beta
0.76
Next Earnings
May 13, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BMEA Overview

Biomea Fusion, Inc. is a preclinical-stage biopharmaceutical company focused on the development of irreversible small molecule drugs to treat patients with genetically defined cancers. Its lead candidate, BMF-219, is designed to taken orally to inhibit MENIN, a transcriptional regulator known to play a direct role in oncogenic signaling in multiple cancers. The company is also using its proprietary FUSION™ System platform to advance a pipeline of covalent treatments against other key oncogenic drivers of cancer. The company was incorporated in 2017 and is headquartered in Redwood City, CA.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BMEA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BMEA ($12.98) is overvalued by 241.94% relative to our estimate of its Fair Value price of $3.80 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BMEA ($12.98) is not significantly undervalued (241.94%) relative to our estimate of its Fair Value price of $3.80 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BMEA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BMEA due diligence checks available for Premium users.

Be the first to know about important BMEA news, forecast changes, insider trades & much more!

BMEA News

Valuation

BMEA fair value

Fair Value of BMEA stock based on Discounted Cash Flow (DCF)
Price
$12.98
Fair Value
$3.80
Overvalued by
241.94%
BMEA ($12.98) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BMEA ($12.98) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BMEA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BMEA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-3.77x
Industry
14.72x
Market
42.64x

BMEA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.75x
Industry
5.93x
BMEA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BMEA's financial health

Profit margin

Revenue
$0.0
Net Income
-$34.9M
Profit Margin
0%
BMEA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$199.9M
Liabilities
$30.7M
Debt to equity
0.18
BMEA's short-term assets ($179.18M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BMEA's short-term assets ($179.18M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BMEA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$22.8M
Investing
-$8.0k
Financing
$622.0k
BMEA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BMEA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BMEA$465.84M-2.26%-3.77x2.75x
FULC$464.51M-3.97%-4.72x1.98x
TBPH$462.86M+7.61%-9.61x2.17x
THRD$469.03M-3.84%-14.77x1.74x
MRSN$462.16M+2.42%-2.57x12.52x

Biomea Fusion Stock FAQ

What is Biomea Fusion's quote symbol?

(NASDAQ: BMEA) Biomea Fusion trades on the NASDAQ under the ticker symbol BMEA. Biomea Fusion stock quotes can also be displayed as NASDAQ: BMEA.

If you're new to stock investing, here's how to buy Biomea Fusion stock.

What is the 52 week high and low for Biomea Fusion (NASDAQ: BMEA)?

(NASDAQ: BMEA) Biomea Fusion's 52-week high was $43.69, and its 52-week low was $8.13. It is currently -70.29% from its 52-week high and 59.75% from its 52-week low.

How much is Biomea Fusion stock worth today?

(NASDAQ: BMEA) Biomea Fusion currently has 35,889,360 outstanding shares. With Biomea Fusion stock trading at $12.98 per share, the total value of Biomea Fusion stock (market capitalization) is $465.84M.

Biomea Fusion stock was originally listed at a price of $18.60 in Apr 16, 2021. If you had invested in Biomea Fusion stock at $18.60, your return over the last 2 years would have been -30.22%, for an annualized return of -16.46% (not including any dividends or dividend reinvestments).

How much is Biomea Fusion's stock price per share?

(NASDAQ: BMEA) Biomea Fusion stock price per share is $12.98 today (as of Apr 12, 2024).

What is Biomea Fusion's Market Cap?

(NASDAQ: BMEA) Biomea Fusion's market cap is $465.84M, as of Apr 14, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Biomea Fusion's market cap is calculated by multiplying BMEA's current stock price of $12.98 by BMEA's total outstanding shares of 35,889,360.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.